ACCESSION: MSBNK-SMB_Measured-HSA001P0072002
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.14, Processed 2025.02.21, Annotated 2025.04.02, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 33
COMMENT: RAW_SPEC {'BLK01_9088': {'bp': 598635.0, 'sum': 943598.0}, 'BLK02_8794': {'bp': 597108.0, 'sum': 897599.0}, 'BLK01_8899': {'bp': 596321.0, 'sum': 958421.0}, 'BLK02_8609': {'bp': 592085.0, 'sum': 891641.0}, 'BLK01_9001': {'bp': 580097.0, 'sum': 906854.0}, 'BLK02_9008': {'bp': 562190.0, 'sum': 860934.0}, 'BLK02_9089': {'bp': 550777.0, 'sum': 853356.0}, 'BLK02_8503': {'bp': 544711.0, 'sum': 835490.0}, 'BLK02_8712': {'bp': 544253.0, 'sum': 814640.0}, 'BLK02_8881': {'bp': 542006.0, 'sum': 814249.0}, 'BLK01_8816': {'bp': 503396.0, 'sum': 833836.0}, 'ProcedureBlank_8630': {'bp': 482936.0, 'sum': 770940.0}, 'ProcedureBlank_8525': {'bp': 477179.0, 'sum': 740288.0}, 'ProcedureBlank_8797': {'bp': 475361.0, 'sum': 758953.0}, 'BLK01_8606': {'bp': 471149.0, 'sum': 814947.0}, 'ProcedureBlank_8881': {'bp': 463192.0, 'sum': 740182.0}, 'BLK01_8524': {'bp': 454394.0, 'sum': 787547.0}, 'ProcedureBlank_8712': {'bp': 449367.0, 'sum': 733053.0}, 'ProcedureBlank_8965': {'bp': 440450.0, 'sum': 716436.0}, 'ProcedureBlank_9047': {'bp': 440403.0, 'sum': 709593.0}, 'BLK01_8733': {'bp': 439902.0, 'sum': 748682.0}, 'BLK01_8398': {'bp': 427896.0, 'sum': 786324.0}, '1_posi_8819': {'bp': 394837.0, 'sum': 676872.0}, '1_posi_8628': {'bp': 379428.0, 'sum': 652379.0}, '1_posi_8733': {'bp': 371431.0, 'sum': 632406.0}, '1_posi_8898': {'bp': 368155.0, 'sum': 613252.0}, '1_posi_8503': {'bp': 365027.0, 'sum': 628363.0}, '1_posi_8357': {'bp': 352682.0, 'sum': 585448.0}, '1_posi_8982': {'bp': 350566.0, 'sum': 592917.0}, '1_posi_9068': {'bp': 348019.0, 'sum': 573972.0}, '2_posi_8945': {'bp': 306662.0, 'sum': 546271.0}, '3_posi_8966': {'bp': 267257.0, 'sum': 464736.0}, '3_posi_9092': {'bp': 248066.0, 'sum': 439632.0}}
COMMENT: RETENTION_TIME_STDEV 0.429
COMMENT: PRECURSOR_M/Z_RAW 72.081284
COMMENT: PRECURSOR_M/Z_STDEV 0.000037
COMMENT: PRECURSOR_IN_MS1 ND
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.507; C4H9N; [M+H]+; delta(ppm) 0.506518
COMMENT: PROPOSED_MF MS-FINDER 3.143; C4H9N; [M+H]+; delta(ppm) 0.489362
COMMENT: PROPOSED_MF SIRIUS5_Sirius 10.703; C4H9N; [M+H]+; delta(ppm) 0.489362
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C4H9N; [M+H]+; delta(ppm) 0.489362
COMMENT: PROPOSED_MF SIRIUS6_Sirius 20.483; C4H9N; [M+H]+; delta(ppm) 0.489362
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C4H9N; [M+H]+; delta(ppm) 0.489362
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.460; KZZKOVLJUKWSKX-UHFFFAOYSA-N; [M+H]+; C1CC(C1)N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.435; ASVKKRLMJCWVQF-UHFFFAOYSA-N; [M+H]+; NCCC=C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.429; UJGVUACWGCQEAO-UHFFFAOYSA-N; [M+H]+; CCN1CC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.357; FGRJGEWVJCCOJJ-UHFFFAOYSA-N; [M+H]+; CC1(CN1)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.286; RWRDLPDLKQPQOW-UHFFFAOYSA-N; [M+H]+; C1CCNC1
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.924; RWRDLPDLKQPQOW-UHFFFAOYSA-N; [M+H]+; Pyrrolidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.611; FGRJGEWVJCCOJJ-UHFFFAOYSA-N; [M+H]+; 2,2-dimethylaziridine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.611; UJGVUACWGCQEAO-UHFFFAOYSA-N; [M+H]+; 1-ethylaziridine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.334; IOXXVNYDGIXMIP-UHFFFAOYSA-N; [M+H]+; N-methylprop-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.334; KZZKOVLJUKWSKX-UHFFFAOYSA-N; [M+H]+; cyclobutanamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.247; ASVKKRLMJCWVQF-UHFFFAOYSA-N; [M+H]+; 3-buten-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; ASVKKRLMJCWVQF-UHFFFAOYSA-N; [M+H]+; 3-buten-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.976; KZZKOVLJUKWSKX-UHFFFAOYSA-N; [M+H]+; cyclobutanamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.947; FGRJGEWVJCCOJJ-UHFFFAOYSA-N; [M+H]+; 2,2-dimethylaziridine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.798; RWRDLPDLKQPQOW-UHFFFAOYSA-N; [M+H]+; Pyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.594; IOXXVNYDGIXMIP-UHFFFAOYSA-N; [M+H]+; N-methylprop-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.558; UJGVUACWGCQEAO-UHFFFAOYSA-N; [M+H]+; 1-ethylaziridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.702; RWRDLPDLKQPQOW-UHFFFAOYSA-N; [M+H]+; pyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.333; QFUSOYKIDBRREL-NSCUHMNNSA-N; [M+H]+; (E)-but-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.287; KZZKOVLJUKWSKX-UHFFFAOYSA-N; [M+H]+; cyclobutanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.276; CSWPOLMVXVBCSV-UHFFFAOYSA-N; [M+H]+; 2-ethylaziridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.262; IGSKHXTUVXSOMB-UHFFFAOYSA-N; [M+H]+; cyclopropylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.173; VXDHQYLFEYUMFY-UHFFFAOYSA-N; [M+H]+; 2-methylprop-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.155; VSRXAWSAKJABKW-UHFFFAOYSA-N; [M+H]+; 1-methylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.148; JDCBWJCUHSVVMN-UHFFFAOYSA-N; [M+H]+; but-3-en-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.146; PYTANBUURZFYHD-UHFFFAOYSA-N; [M+H]+; 2-methylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.049; ASVKKRLMJCWVQF-UHFFFAOYSA-N; [M+H]+; but-3-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.984; DLBWPRNUXWYLRN-UHFFFAOYSA-N; [M+H]+; 2-methylazetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.984; HTHMVKNHGOVITA-UHFFFAOYSA-N; [M+H]+; 3-methylazetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.982; FGRJGEWVJCCOJJ-UHFFFAOYSA-N; [M+H]+; 2,2-dimethylaziridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.863; IOXXVNYDGIXMIP-UHFFFAOYSA-N; [M+H]+; N-methylprop-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.695; VEBLEROFGPOMPB-UHFFFAOYSA-N; [M+H]+; N-methylcyclopropanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -44.706; JDCBWJCUHSVVMN; [M+H]+; 3-Buten-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -63.414; KZZKOVLJUKWSKX; [M+H]+; Cyclobutanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -64.517; IOXXVNYDGIXMIP; [M+H]+; Allylmethylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -64.791; QFUSOYKIDBRREL; [M+H]+; Crotylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -64.831; VXDHQYLFEYUMFY; [M+H]+; Methallylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -68.406; IGSKHXTUVXSOMB; [M+H]+; Cyclopropylmethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -75.613; RWRDLPDLKQPQOW; [M+H]+; Azolidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -77.613; ASVKKRLMJCWVQF; [M+H]+; 3-Buten-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -78.347; PYTANBUURZFYHD; [M+H]+; Cyclopropanamine, 2-methyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -119.192; UJGVUACWGCQEAO; [M+H]+; 1-ethylaziridine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -125.388; VSRXAWSAKJABKW; [M+H]+; Ambcb4021534
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -132.294; CSWPOLMVXVBCSV; [M+H]+; Butyleneimine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -133.574; VEBLEROFGPOMPB; [M+H]+; Cyclopropyl-methylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -138.307; FGRJGEWVJCCOJJ; [M+H]+; 2,2-Dimethylaziridine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -145.609; HNPYZRNUMNPTAQ; [M+H]+; Dimethyl aziridinium
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.381; JDCBWJCUHSVVMN; [M+H]+; 3-Buten-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -47.362; IGSKHXTUVXSOMB; [M+H]+; Cyclopropanemethylamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -48.855; KZZKOVLJUKWSKX; [M+H]+; Cyclobutylamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -55.888; VSRXAWSAKJABKW; [M+H]+; 1-(Trideuteriomethyl)cyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -58.854; QFUSOYKIDBRREL; [M+H]+; 2-Butenylamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -60.088; FGRJGEWVJCCOJJ; [M+H]+; 2,2-Dimethylaziridine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -60.247; VXDHQYLFEYUMFY; [M+H]+; 2-Methylallylamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -63.147; PYTANBUURZFYHD; [M+H]+; (1R)-2-methylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -64.831; IOXXVNYDGIXMIP; [M+H]+; Methyl(prop-2-enyl)azanium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -73.536; RWRDLPDLKQPQOW; [M+H]+; 2,2,3-Trideuteriopyrrolidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -78.110; JDCBWJCUHSVVMN; [M+H]+; 2-Deuteriobut-3-en-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.240; IGSKHXTUVXSOMB; [M+H]+; Cyclopropanemethylamine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C4H10N1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 17.628
MS$FOCUSED_ION: PRECURSOR_M/Z 72.080811
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-00di-9000000000-064a4d4332d7cea642a5
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  53.0386774 10.1467 53.039300 1.2444 2.43 0.5388 31 f{C4H5}/1.90ppm,p-H5N1
  55.0543610 195.4876 55.054990 0.2543 27.99 0.7884 33 f{C4H7}/2.44ppm,p-H3N1
  56.0495483 16.0630 56.050180 0.6601 3.54 0.7667 33 f{C3H6N1}/1.30ppm,p-C1H4
  57.0574259 117.2146 57.058060 0.3330 16.04 0.8048 33 f{C3H7N1}/2.20ppm,p-C1H3
  72.0444235 209.3999 72.045030 0.3054 68.88 0.3095 33 ?
  72.0574986 12.9213 72.058105 1.4294 4.91 -0.0850 32 ?
  72.0637436 53.0255 72.064350 0.8603 17.12 0.1360 33 ?
  72.0808037 999.0000 72.081410 0.2081 0.00 1.0000 33 f{C4H10N1}/0.39ppm,p
PK$NUM_PEAK: 8
PK$PEAK: m/z int. rel.int.
  53.038677 10.15 10
  55.054361 195.49 195
  56.049548 16.06 16
  57.057426 117.21 117
  72.044423 209.40 209
  72.057499 12.92 12
  72.063744 53.03 53
  72.080804 999.00 999
//
